|
USP9X expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.4798000004872E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.565400E-04 |
| Normal-vs-Stage2 |
8.31880000000673E-05 |
| Normal-vs-Stage3 |
1.01529999996242E-06 |
| Normal-vs-Stage4 |
4.584100E-04 |
| Stage1-vs-Stage2 |
1.831820E-01 |
| Stage1-vs-Stage3 |
2.770200E-02 |
| Stage1-vs-Stage4 |
1.927400E-01 |
| Stage2-vs-Stage3 |
6.320000E-01 |
| Stage2-vs-Stage4 |
9.132200E-01 |
| Stage3-vs-Stage4 |
7.532200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.45449999999769E-06 |
| Normal-vs-AfricanAmerican |
8.4485000000023E-05 |
| Normal-vs-Asian |
8.582200E-01 |
| Caucasian-vs-AfricanAmerican |
2.124000E-01 |
| Caucasian-vs-Asian |
1.042010E-01 |
| AfricanAmerican-vs-Asian |
6.646000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.7150000025955E-08 |
| Normal-vs-Female |
3.236000E-02 |
| Male-vs-Female |
1.552620E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.782100E-02 |
| Normal-vs-Age(41-60Yrs) |
1.972880E-04 |
| Normal-vs-Age(61-80Yrs) |
4.92590000011894E-07 |
| Normal-vs-Age(81-100Yrs) |
8.11210000000173E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.962200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.924000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.051400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.902430E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.948200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.569000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.907800E-01 |
| Normal-vs-Grade 2 |
3.165200E-04 |
| Normal-vs-Grade 3 |
2.59859999995893E-06 |
| Normal-vs-Grade 4 |
2.05379999673738E-08 |
| Grade 1-vs-Grade 2 |
4.227600E-01 |
| Grade 1-vs-Grade 3 |
2.332000E-01 |
| Grade 1-vs-Grade 4 |
1.923910E-02 |
| Grade 2-vs-Grade 3 |
1.399760E-01 |
| Grade 2-vs-Grade 4 |
4.021200E-03 |
| Grade 3-vs-Grade 4 |
1.494170E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.404650E-04 |
| Normal-vs-ccB subtype |
1.358470E-03 |
| ccA subtype-vs-ccB subtype |
8.109400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.98920000000258E-05 |
| Normal-vs-N1 |
1.804000E-01 |
| N0-vs-N1 |
9.902800E-01 |
|
|
